These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22447481)

  • 1. New ESC/EASD lipid guidelines empahsises need to expand cholesterol screening and treating to target in clinical practice.
    Aalbers J
    Cardiovasc J Afr; 2012 Mar; 23(2):118-20. PubMed ID: 22447481
    [No Abstract]   [Full Text] [Related]  

  • 2. Are we lowering LDL cholesterol sufficiently?
    Barter P; Rye KA
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
    [No Abstract]   [Full Text] [Related]  

  • 3. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A focus on cardiovascular risk modification: clinical significance and implementation of the 2013 ACC/AHA cholesterol guidelines.
    Kelly SC; Gonzalo R; Petrasko M
    S D Med; 2014 Aug; 67(8):320-3. PubMed ID: 25163226
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
    MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
    [No Abstract]   [Full Text] [Related]  

  • 6. Rising to the challenge of treating high-risk patients.
    Guthrie RM
    Am J Manag Care; 2006 Oct; 12(11 Suppl):S318-24. PubMed ID: 17042674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
    Tonkin A; Barter P; Best J; Boyden A; Furler J; Hossack K; Sullivan D; Thompson P; Vale M; Cooper C; Robinson M; Clune E; ;
    Heart Lung Circ; 2005 Dec; 14(4):275-91. PubMed ID: 16361000
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholesterol screening in children: makes sense but what is the impact?
    Rohatgi A
    Future Cardiol; 2010 May; 6(3):275-80. PubMed ID: 20462333
    [No Abstract]   [Full Text] [Related]  

  • 10. [Statins: for the time being, do not as a rule prescribe the maximum dose].
    van der Harst P; Kastelein JJ; van Gilst WH
    Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2589; author reply 2589-90. PubMed ID: 16320673
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cholesterol--when is preventive treatment with statin indicated?].
    Stender S; Nordestgaard BG
    Ugeskr Laeger; 2011 Jun; 173(24):1747; author reply 1747. PubMed ID: 21834202
    [No Abstract]   [Full Text] [Related]  

  • 12. An update to the National Cholesterol Education Program: 2009 suggested changes.
    Medina-Ruíz A
    Bol Asoc Med P R; 2009; 101(4):30-3. PubMed ID: 20853557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin treatment of rheumatoid arthritis: comment on the editorial by Ridker and Solomon.
    Peters MJ; Nurmohamed MT; Kitas GD; Sattar N
    Arthritis Rheum; 2010 Jan; 62(1):302-3. PubMed ID: 20039426
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of dyslipidemia in renal disease and transplantation.
    Zolezzi M
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):129-36. PubMed ID: 16903617
    [No Abstract]   [Full Text] [Related]  

  • 16. New AHA-ACC guidelines could lead to major changes in clinical practice.
    Rosenberg K
    Am J Nurs; 2014 Feb; 114(2):13. PubMed ID: 24481346
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe.
    Thompson GR; Catapano A; Saheb S; Atassi-Dumont M; Barbir M; Eriksson M; Paulweber B; Sijbrands E; Stalenhoef AF; Parhofer KG
    Curr Opin Lipidol; 2010 Dec; 21(6):492-8. PubMed ID: 20935563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [European guidelines for lipid treatment are tailored according to risk level].
    Wiklund O
    Lakartidningen; 2012 Sep 19-26; 109(38):1653. PubMed ID: 23094394
    [No Abstract]   [Full Text] [Related]  

  • 20. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
    Ridker PM
    J Am Coll Cardiol; 2007 May; 49(21):2129-38. PubMed ID: 17531663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.